Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
28-Sep-16 AIA Korea and SK Holdings have announced an MOU to develop Korea’s leading customer centric integrated digital health and wellness ecosystem. The companies aim to help motivate customers change and adopt a healthier lifestyle to reduce major chronic illnesses stemming from smoking, drinking, poor diet and lack of physical exercise. [image: Business Korea]Read More
26-Sep-16 The Hong Kong Eye Hospital will hire four additional staff members for its eye cornea donation team in the hopes of boosting transplant cases by 25%. The public hospital, which runs the city’s only eye bank, currently has a 15-member team responsible for coordinating cornea donations for some 400 eye patients. [image: South China Morning Post]Read More
26-Sep-16 Small specialised hospitals in India are planning to collaborate to expand services across the country by pooling medical expertise for maximum efficiency. “We have strong investment backing... We have planned expansion to increase to 1,000-bed facilities, from the current 108-bed hospital in Bangalore,” said Dr Anil Mehta, MD of Bangalore-based Nandana Healthcare. [image: Medical Dialogues]Read More
23-Sep-16 Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism. The zone in Boao is likely to attract patients who would otherwise travel to Hong Kong or Macau for drugs yet to be approved in China. [image: Anthony Wallace / AFP / Getty Images]Read More
21-Sep-16 SK has signed an MOU with Korea University on the development of the 'Aibril' Infectious Disease AI Diagnosis Service, based on Watson. This will be a world first, as up to now AI-based medical services have been mainly limited to diagnosing cancers. No-one has yet provided AI medical services for infectious diseases such as Middle East Respiratory Syndrome and Cholera. [image: Business Korea]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: